SCHEMBL10076846

SCHEMBL10076846

CCC[C@H](NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)OCc1ccccc1)C1CCCCC1)C(C)C)C(O)C(=O)NC1CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 2/20 0.42
ACE P12821 6/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
USP2 O75604 1/20 0.41
LMNA P02545 1/20 0.41
ELANE P08246 1/20 0.39
CYP3A4 P08684 3/20 0.39
ALOX15 P16050 1/20 0.39
CTSL P07711 1/20 0.39
CTSB P07858 1/20 0.39
CTSK P43235 1/20 0.39
CCR1 P32246 1/20 0.39
MALT1 Q9UDY8 1/20 0.39
TSHR P16473 2/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
HTRA1 Q92743 1/20 0.37
TP53 P04637 1/20 0.37
CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13613236 0.91 HTRA1 (0.39) ACEMEN1KMT2AUSP2LMNA
SCHEMBL14350234 0.91 HTRA1 (0.39) ACEMEN1KMT2AUSP2LMNA
SCHEMBL14376884 0.91 HTRA1 (0.39) ACEMEN1KMT2AUSP2LMNA
SCHEMBL10076845 0.91 HTRA1 (0.39) ACEMEN1KMT2AUSP2LMNA
SCHEMBL3050903 0.91 HTRA1 (0.39) ACEMEN1KMT2AUSP2LMNA
SCHEMBL10076848 0.87 ACE (0.41) F2ACEMEN1KMT2AUSP2
SCHEMBL13613239 0.87 ACE (0.41) F2ACEMEN1KMT2AUSP2
SCHEMBL3052690 0.87 ACE (0.41) F2ACEMEN1KMT2AUSP2
SCHEMBL14350258 0.87 ACE (0.41) F2ACEMEN1KMT2AUSP2
SCHEMBL13613245 0.78 CTSB (0.40) F2ELANECTSLCTSBCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2468744-A2 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-06-27 EP disclosed